High-throughput screening of mouse knockout lines identifies true lean and obese phenotypes

Obesity

Volumn 16, Issue 10, 2008, Pages 2362-2367

  Brommage, Robert ^a   Desai, Urvi ^a   Revelli, Jean Pierre ^a   Donoviel, Dorit B ^a   Fontenot, Gregory K ^a   DaCosta, Christopher M ^a   Smith, Deon D ^a   Kirkpatrick, Laura L ^a   Coker, Kenneth J ^a   Donoviel, Michael S ^a   Eberhart, Derek E ^a   Holt, Kathleen H ^a   Kelly, Michael R ^a   Paradee, William J ^a   Philips, Anne V ^a   Platt, Kenneth A ^a   Suwanichkul, Adisak ^a   Hansen, Gwenn M ^a   Sands, Arthur T ^a   Zambrowicz, Brian P ^a   Powell, David R ^a   more..

^a LEXICON PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOSE TISSUE; ANIMAL; ARTICLE; BODY WEIGHT; COMPARATIVE STUDY; DISEASE MODEL; FAT INTAKE; FEMALE; GENETICS; GENOTYPE; MALE; MOUSE; MOUSE MUTANT; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PATHOPHYSIOLOGY; PHENOTYPE; PHOTON ABSORPTIOMETRY; RADIOGRAPHY; REPRODUCIBILITY;

ABSORPTIOMETRY, PHOTON; ADIPOSE TISSUE; ADIPOSITY; ANIMALS; DIETARY FATS; DISEASE MODELS, ANIMAL; FEMALE; GENOTYPE; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, KNOCKOUT; OBESITY; PHENOTYPE; REPRODUCIBILITY OF RESULTS; THINNESS;

MAMMALIA; MUS;

EID: 53849119117     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2008.361     Document Type: Article

References (49)

1. Wang Y, Beydoun MA. The obesity epidemic in the United States - gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev 2007;29:6-28.
2. James WP, Rigby N, Leach R. Obesity and the metabolic syndrome: the stress on society. Ann N Y Acad Sci 2006;1083:1-10.
3. Challis BG, Yeo GSH. Past, present and future strategies to study the genetics of body weight regulation. Brief Funct Genomic Proteomic 2002;1:290-304.
4. International Mouse Knockout Consortium, Collins FS, Rossant J, Wurst W. A mouse for all reasons. Cell 2007;128:9-13.
5. Zambrowicz BP, Sands AT. Knockouts model the 100 best-selling drugs - will they model the next 100? Nat Rev Drug Discov 2003;2:38-51.
6. Zambrowicz BP, Abuin A, Ramirez-Solis R et al. Wnk1 kinase deficiency lowers blood pressure in mice: a gene-trap screen to identify potential targets for therapeutic intervention. Proc Natl Acad Sci USA 2003;100:14109-14114.
7. BeltrandelRio H, Kern F, Lanthorn T et al. Saturation screening of the druggable mammalian genome. In: Carroll PM, Fitzgerald K (eds). Model Organisms in Drug Discovery. Wiley & Sons: Chichester, England, 2003, pp 251-278.
8. Powell DR. Obesity drugs and their targets: correlation of mouse knockout phenotypes with drug effects in vivo. Obes Rev 2006;7:89-108.
9. Wattler S, Kelly M, Nehls M. Construction of gene targeting vectors from lambda KOS genomic libraries. Biotechniques 1999;26:1150-1160.
10. Zambrowicz BP, Holt KH, Walke DW, Kirkpatrick LL, Eberhart DE. Generation of Transgenic Animals. In: Metcalf BW, Dillon S (eds). Target Validation in Drug Discovery. Academic Press: London, 2007, pp 3-26.
11. Donoviel DB, Freed DD, Vogel OH et al. Proteinuria and perinatal lethality in mice lacking NEPH1, a novel protein with homology to NEPHRIN. Mol Cell Biol 2001;21:4829-4836.
12. Zhang W, Rajan I, Savelieva KV et al. Netrin-G2 and netrin-G2 ligand are both required for normal auditory responsiveness. Genes Brain Behav 2008;7:385-392.
13. Brommage R. Validation and calibration of DEXA body composition in mice. Am J Physiol Endocrinol Metab 2003;285:E454-E459.
14. Martinez-Botas J, Anderson JB, Tessier D et al. Absence of perilipin results in leanness and reverses obesity in Lepr(db/db) mice. Nat Genet 2000;26:474-479.
15. Tansey JT, Sztalryd C, Gruia-Gray J et al. Perilipin ablation results in a lean mouse with aberrant adipocyte lipolysis, enhanced leptin production, and resistance to diet-induced obesity. Proc Natl Acad Sci USA 2001;98:6494-6499.
16. Cohen P, Miyazaki M, Socci ND et al. Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss. Science 2002;297:240-243.
17. Ntambi JM, Miyazaki M, Stoehr JP et al. Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity. Proc Natl Acad Sci USA 2002;99:11482-11486.
18. Cota D, Marsicano G, Tschop M et al. The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J Clin Invest 2003;112:423-431.
19. Ravinet Trillou C, Delgorge C, Menet C, Arnone M, Soubrié P. CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity. Int J Obes Relat Metab Disord 2004;28:640-648.
20. Marsh DJ, Weingarth DT, Novi DE et al. Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphagic and have altered metabolism. Proc Natl Acad Sci USA 2002;99:3240-3245.
21. Chen Y, Hu C, Hsu CK et al. Targeted disruption of the melanin-concentrating hormone receptor-1 results in hyperphagia and resistance to diet-induced obesity. Endocrinology 2002;143:2469-2477.
22. Elchebly M, Payette P, Michaliszyn E et al. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 1999;283:1544-1548.
23. Klaman LD, Boss O, Peroni OD et al. Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol Cell Biol 2000;20:5479-5489.
24. Zabalotny JM, Bence-Hanulec KK, Stricker-Krongrad A et al. PTP1B regulates leptin signal transduction in vivo. Dev Cell 2002;2:489-495.
25. Lamia KA, Peroni OD, Kim YB et al. Increased insulin sensitivity and reduced adiposity in phosphatidylinositol 5-phosphate 4-kinase beta-/- mice. Mol Cell Biol 2004;24:5080-5087.
26. Hammond LE, Gallagher PA, Wang S et al. Mitochondrial glycerol-3-phosphate acyltransferase-deficient mice have reduced weight and liver triacylglycerol content and altered glycerolipid fatty acid composition. Mol Cell Biol 2002;22:8204-8214.
27. Neschen S, Morino K, Hammond LE et al. Prevention of hepatic steatosis and hepatic insulin resistance in mitochondrial acyl-CoA:glycerol-sn- 3-phosphate acyltransferase 1 knockout mice. Cell Metab 2005;2:55-65.
28. Sainsbury A, Schwarzer C, Couzens M et al. Y4 receptor knockout rescues fertility in ob/ob mice. Genes Dev 2002;16:1077-1088.
29. Sainsbury A, Baldock PA, Schwarzer C et al. Synergistic effects of Y2 and Y4 receptors on adiposity and bone mass revealed in double knockout mice. Mol Cell Biol 2003;23:5225-5233.
30. Sainsbury A, Bergen HT, Boey D et al. Y2Y4 receptor double knockout protects against obesity due to a high-fat diet or Y1 receptor deficiency in mice. Diabetes 2006;55:19-26.
31. Butler AA, Kesterson RA, Khong K et al. A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology 2000;141:3518-3521.
32. Chen AS, Marsh DJ, Trumbauer ME et al. Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat Genet 2000;26:97-102.
33. Sutton GM, Trevaskis JL, Hulver MW et al. Diet-genotype interactions in the development of the obese, insulin-resistant phenotype of C57BL/6J mice lacking melanocortin-3 or -4 receptors. Endocrinology 2006;147:2183-2196.
34. Huszar D, Lynch CA, Fairchild-Huntress V et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997;88:131-141.
35. Ste Marie L, Miura GI, Marsh DJ, Yagaloff K, Palmiter RD. A metabolic defect promotes obesity in mice lacking melanocortin-4 receptors. Proc Natl Acad Sci USA 2000;97:12339-12344.
36. Weide K, Christ N, Moar K et al. Hyperphagia, not hypermetabolism, causes early onset obesity in melanocortin-4 receptor knockout mice. Physiol Genomics 2003;13:47-56.
37. Chennathukuzhi V, Stein JM, Abel T et al. Mice deficient for testis-brain RNA-binding protein exhibit a coordinate loss of TRAX, reduced fertility, altered gene expression in the brain, and behavioral changes. Mol Cell Biol 2003;23:6419-6434.
38. Ohki-Hamazaki H, Watase K, Yamamoto K et al. Mice lacking bombesin receptor subtype-3 develop metabolic defects and obesity. Nature 1997;390:165-169.
39. Maekawa F, Quah HM, Tanaka K, Ohki-Hamazaki H. Leptin resistance and enhancement of feeding facilitation by melanin-concentrating hormone in mice lacking bombesin receptor subtype-3. Diabetes 2004;53:570-576.
40. Tecott LH, Sun LM, Akana SF et al. Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors. Nature 1995;374:542-546.
41. Nonogaki K, Strack AM, Dallman MF, Tecott LH. Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene. Nat Med 1998;4:1152-1156.
42. Tinsley FC, Taicher GZ, Heiman ML. Evaluation of a quantitative magnetic resonance method for mouse whole body composition analysis. Obes Res 2004;12:150-160.
43. Dalton GL, Lee MD, Kennett GA, Dourish CT, Clifton PG. mCPP-induced hyperactivity in 5-HT2C receptor mutant mice is mediated by activation of multiple 5-HT receptor subtypes. Neuropharmacology 2004;46:663-671.
44. Heisler LK, Tecott LH. A paradoxical locomotor response in serotonin 5-HT(2C) receptor mutant mice. J Neurosci 2000;20:RC71.
45. Boudeau J, Miranda-Saavedra D, Barton GJ, Alessi DR. Emerging roles of pseudokinases. Trends Cell Biol 2006;16:443-452.
46. Channavajhala PL, Wu L, Cuozzo JW et al. Identification of a novel human kinase supporter of Ras (hKSR-2) that functions as a negative regulator of Cot (Tpl2) signaling. J Biol Chem 2003;278:47089-47097.
47. Channavajhala PL, Rao VR, Spaulding V, Lin LL, Zhang YG. hKSR-2 inhibits MEKK3-activated MAP kinase and NF-kappaB pathways in inflammation. Biochem Biophys Res Commun 2005;334:1214-1218.
48. Hirosumi J, Tuncman G, Chang L et al. A central role for JNK in obesity and insulin resistance. Nature 2002;420:333-336.
49. Brommage R, Shi ZZ, Liu J et al. High-throughput DEXA and micro-CT analyses of bone in gene knockout mice to identify novel osteoporosis drug targets. J Bone Miner Res 2006;21(Suppl 1):S88.